Stock Rich List
Nasdaq: NTLA

Intellia Therapeutics insiders

The officers, directors and 10% owners of Intellia Therapeutics, Inc. who hold the most stock, valued at the live NTLA price.

$9.52
NTLA today −$250K (−2.56%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
6
Their NTLA stock
$17.2M
Market value
$1.34B
Held by ranked insiders
1.28%

Insiders by value of NTLA holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1John M. LeonardPresident and CEO1,196,479$11.4M0.85%6217th
2Fred E. CohenDirector216,653$2.1M0.15%6366th
3Jing L. MarantzEVP, Chief Medical Officer199,822$1.9M0.14%10139th
4William ChaseDirector143,893$1.4M0.10%12947th
5Brian GoffDirector32,609$310K<0.1%13359th
6Caroline DorsaDirector12,701$121K<0.1%7384th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Intellia Therapeutics; see each profile for the filing.